Act.in.Sarc: An International Randomized Phase III Trial Evaluating Efficacy and Safety of First-in-Class NBTXR3 Hafnium Oxide Nanoparticles Activated By Preoperative Radiotherapy in Locally Advanced Soft Tissue Sarcoma

Bonvalot, S.;Rutkowski, P.;Thariat, J. O.;Carrere, S.;Sunyach, M. P.;Saada, E.;Ágoston, P.;Hong, A.;Mervoyer, A.;Rastrelli, M.;Le Pechoux, C.;Moreno, V.;Li, R.;Tiangco, B.;Casado, A.;Gronchi, A.;Mangel, L. C.;Hohenberger, P.;Delannes, M.;Papai, Z.

2018